|
Volumn 56, Issue SUPPL. 1, 2001, Pages
|
Antithrombin and anti-Xa agents in the control of thrombogenesis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID;
[N [4 [(1 ACETIMIDOYL 4 PIPERIDYL)OXY]PHENYL] N [(7 AMIDINO 2 NAPHTHYL)METHYL]SULFAMOYL]ACETIC ACID;
ANTICOAGULANT AGENT;
ANTISTASIN;
ARGATROBAN;
BLOOD CLOTTING FACTOR 10A;
CVS 995;
DESULFATOHIRUDIN;
DEXTRO PHENYLALANYLPROLYLARGININAL;
EFEGATRAN;
ENOXAPARIN;
HEPARIN DERIVATIVE;
HIRULOG;
INOGATRAN;
LEPIRUDIN;
LOW MOLECULAR WEIGHT HEPARIN;
MELAGATRAN;
N ACETYL 4 (AMINOIMINOMETHYL)PHENYLALANYL 2 CYCLOHEXYLGLYCYL 3 (1 METHYLPYRIDINIUM 3 YL) ALANYLLEUCYLPROLINAMIDE;
NAPSAGATRAN;
RECOMBINANT HIRUDIN;
SYNTHETIC PEPTIDE;
TERT BUTYLOXYCARBONYL DEXTRO PHENYLALANYLPROLYLARGININAL;
THROMBIN INHIBITOR;
TINZAPARIN;
UNCLASSIFIED DRUG;
YAGIN;
ANIMAL MODEL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DEEP VEIN THROMBOSIS;
DRUG INDUCED DISEASE;
DRUG SYNTHESIS;
HUMAN;
NONHUMAN;
PEPTIDE SYNTHESIS;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RAT;
THROMBOCYTOPENIA;
THROMBOGENESIS;
THROMBOSIS;
THROMBOSIS PREVENTION;
ANIMALS;
FACTOR XA;
FIBRINOLYTIC AGENTS;
HUMANS;
HUNGARY;
THROMBIN;
THROMBOSIS;
|
EID: 0034791924
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (62)
|